These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7508608)

  • 21. Remote monitoring costs, benefits, and reimbursement: a European perspective.
    Chronaki CE; Vardas P
    Europace; 2013 Jun; 15 Suppl 1():i59-i64. PubMed ID: 23737233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remote monitoring of cardiac implantable devices in the Asia-Pacific.
    Lau CP; Zhang S
    Europace; 2013 Jun; 15 Suppl 1():i65-i68. PubMed ID: 23737235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effectiveness of cardiac resynchronization therapy: Futile or useful?
    Exner DV
    Can J Cardiol; 2005 Apr; 21(5):419-22. PubMed ID: 15861259
    [No Abstract]   [Full Text] [Related]  

  • 24. [Interventional therapy of cardiac arrhythmias].
    Pfeiffer D
    Dtsch Med Wochenschr; 2000 Apr; 125(16):506-7. PubMed ID: 10819013
    [No Abstract]   [Full Text] [Related]  

  • 25. Reducing mortality in patients with advanced cardiovascular disease: subgroups, subgroups and more subgroups..
    Saksena S
    J Interv Card Electrophysiol; 2004 Feb; 10(1):7-8. PubMed ID: 15049332
    [No Abstract]   [Full Text] [Related]  

  • 26. Shelf price agreements: a novel approach to competitive bidding for arrhythmia therapy devices.
    Keast RK; Pelosi F; Morady F; Larin LR; Goldstein-Dunn J; Cox D; Michalak CG; Fetyko S; Denton TA; Eagle KA
    J Cardiovasc Manag; 2004; 15(5):12-5. PubMed ID: 15506010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of cardiovascular medicine in Greece: brief notes.
    Vardas PE
    Hellenic J Cardiol; 2012; 53(4):333-4. PubMed ID: 22796825
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost efficiency and reimbursement of remote monitoring: a US perspective.
    Slotwiner D; Wilkoff B
    Europace; 2013 Jun; 15 Suppl 1():i54-i58. PubMed ID: 23737232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Centers for Medicare and Medicaid Services will stop payment for infected cardiac implantable devices; will implantable pain therapy be next?
    Welch M; Attalah J
    Pain Pract; 2013 Feb; 13(2):171. PubMed ID: 23379958
    [No Abstract]   [Full Text] [Related]  

  • 30. Tracing the European course of cardiac resynchronization therapy from 2006 to 2008.
    Merkely B; Roka A; Kutyifa V; Boersma L; Leenhardt A; Lubinski A; Oto A; Proclemer A; Brugada J; Vardas PE; Wolpert C
    Europace; 2010 May; 12(5):692-701. PubMed ID: 20200017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Group purchasing organizations: optimizing cardiac device selection, therapy delivery, and fiscal responsibility.
    Sweesy MW; Wilkoff BL; Smith KW; Holland JL
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1404-9. PubMed ID: 17201849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-of-illness study of patients subjected to cardiac rhythm management devices implantation: results from a single tertiary centre.
    Fanourgiakis J; Simantirakis E; Maniadakis N; Kourlaba G; Kanoupakis E; Chrysostomakis S; Vardas P
    Europace; 2013 Mar; 15(3):366-75. PubMed ID: 23148117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Remote monitoring of implantable cardiac devices: health technology assessment ].
    Ricci RP; Locati ET; Campana A; Cavallaro C; Giammaria M; Landolina M; Marzegalli M; Melissano D
    G Ital Cardiol (Rome); 2015 May; 16(5):295-303. PubMed ID: 25994466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficiency potential in the pacemaker/implantable cardioverter defibrillator outpatient clinic].
    Bauer A; Bauer J; Bauer M; Kelemen K; Voss F; Senges-Becker J; Weretka S; Katus HA; Becker R
    Herzschrittmacherther Elektrophysiol; 2006 Mar; 17(1):26-34. PubMed ID: 16547657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoeconomic considerations in antiarrhythmic therapy.
    Podrid PJ; Arnold RJ; Kaniecki DJ
    Pharmacoeconomics; 1992 Dec; 2(6):456-67. PubMed ID: 10147006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudden death prevention with implantable devices.
    Passman R; Kadish A
    Circulation; 2007 Jul; 116(5):561-71. PubMed ID: 17664385
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S.
    Sridhar AR; Lavu M; Yarlagadda V; Reddy M; Gunda S; Afzal R; Atkins D; Gopinathanair R; Dawn B; Lakkireddy DR
    Pacing Clin Electrophysiol; 2017 Mar; 40(3):286-293. PubMed ID: 28084622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pacemaker battery scandal.
    Dean J; Sulke N
    BMJ; 2016 Feb; 352():i228. PubMed ID: 26848134
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardiac pacemaker and internal defibrillators (ICD). Basic principles and new important developments, status 1998].
    Deisenhofer I; Karch M; Zrenner B; Schmitt C; Schömig A
    Fortschr Med; 1998 Aug; 116(22-23):20-4, 26. PubMed ID: 9773595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac rhythm devices in the pediatric population: utilization and complications.
    Czosek RJ; Meganathan K; Anderson JB; Knilans TK; Marino BS; Heaton PC
    Heart Rhythm; 2012 Feb; 9(2):199-208. PubMed ID: 21907171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.